microRNA information: hsa-miR-500a-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-500a-3p | miRbase |
Accession: | MIMAT0002871 | miRbase |
Precursor name: | hsa-mir-500a | miRbase |
Precursor accession: | MI0003184 | miRbase |
Symbol: | NA | HGNC |
RefSeq ID: | NA | GenBank |
Sequence: | AUGCACCUGGGCAAGGAUUCUG |
Reported expression in cancers: hsa-miR-500a-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-500a-3p | gastric cancer | upregulation | "Furthermore we found that miR-500 promoted gastric ......" | 25595906 |
Reported cancer pathway affected by hsa-miR-500a-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-500a-3p | breast cancer | Apoptosis pathway | "In addition re-expression of ERα in ERα-negative ......" | 27304060 |
Reported cancer prognosis affected by hsa-miR-500a-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-500a-3p | breast cancer | poor survival; drug resistance | "In addition re-expression of ERα in ERα-negative ......" | 27304060 | |
hsa-miR-500a-3p | gastric cancer | poor survival; malignant trasformation; progression | "Here we report that the miR-500 directly repressed ......" | 25595906 | |
hsa-miR-500a-3p | lung cancer | progression | "We succeeded in establishing the MTA1 knockdown NS ......" | 22576802 | RNAi |
Reported gene related to hsa-miR-500a-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-500a-3p | breast cancer | LY6K | "In addition re-expression of ERα in ERα-negative ......" | 27304060 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-500a-3p | RAI2 | 11 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.484; TCGA BRCA -0.639; TCGA COAD -0.333; TCGA HNSC -0.309; TCGA LGG -0.135; TCGA LIHC -0.281; TCGA LUSC -0.29; TCGA PRAD -0.21; TCGA SARC -0.204; TCGA THCA -0.328; TCGA STAD -0.577 |
hsa-miR-500a-3p | DAAM1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; OV; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.25; TCGA BRCA -0.182; TCGA ESCA -0.255; TCGA HNSC -0.369; TCGA LIHC -0.172; TCGA OV -0.132; TCGA PRAD -0.239; TCGA SARC -0.287; TCGA STAD -0.217 |
hsa-miR-500a-3p | ZFHX4 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; OV; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.57; TCGA BRCA -0.321; TCGA COAD -0.941; TCGA ESCA -0.609; TCGA HNSC -0.4; TCGA KIRP -0.434; TCGA LGG -0.284; TCGA OV -0.186; TCGA PRAD -0.279; TCGA STAD -0.634 |
hsa-miR-500a-3p | RBMS1 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.095; TCGA CESC -0.237; TCGA COAD -0.435; TCGA ESCA -0.358; TCGA HNSC -0.103; TCGA KIRP -0.054; TCGA LIHC -0.127; TCGA LUAD -0.073; TCGA LUSC -0.116; TCGA OV -0.053; TCGA PAAD -0.261; TCGA PRAD -0.302; TCGA THCA -0.057; TCGA STAD -0.272; TCGA UCEC -0.219 |
hsa-miR-500a-3p | NFAT5 | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.194; TCGA BRCA -0.075; TCGA ESCA -0.095; TCGA HNSC -0.197; TCGA KIRP -0.208; TCGA LGG -0.083; TCGA LIHC -0.091; TCGA PAAD -0.109; TCGA PRAD -0.175; TCGA SARC -0.067; TCGA THCA -0.073; TCGA UCEC -0.129 |
hsa-miR-500a-3p | ITPRIP | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.266; TCGA CESC -0.159; TCGA COAD -0.297; TCGA ESCA -0.432; TCGA HNSC -0.202; TCGA KIRC -0.339; TCGA LIHC -0.314; TCGA LUSC -0.341; TCGA PRAD -0.252; TCGA STAD -0.256; TCGA UCEC -0.22 |
hsa-miR-500a-3p | CPNE8 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.334; TCGA CESC -0.247; TCGA COAD -0.327; TCGA ESCA -0.327; TCGA HNSC -0.118; TCGA KIRC -0.19; TCGA LIHC -0.137; TCGA PRAD -0.343; TCGA STAD -0.265; TCGA UCEC -0.268 |
hsa-miR-500a-3p | MBNL1 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.22; TCGA CESC -0.114; TCGA COAD -0.065; TCGA ESCA -0.157; TCGA HNSC -0.133; TCGA KIRC -0.165; TCGA KIRP -0.068; TCGA LIHC -0.073; TCGA LUAD -0.07; TCGA PRAD -0.183; TCGA SARC -0.304; TCGA STAD -0.197; TCGA UCEC -0.143 |
hsa-miR-500a-3p | KCTD9 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC | MirTarget | TCGA BLCA -0.129; TCGA CESC -0.169; TCGA ESCA -0.093; TCGA HNSC -0.104; TCGA KIRC -0.117; TCGA LUAD -0.161; TCGA PAAD -0.161; TCGA PRAD -0.197; TCGA SARC -0.159 |
hsa-miR-500a-3p | JMY | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.151; TCGA BRCA -0.17; TCGA COAD -0.112; TCGA ESCA -0.301; TCGA HNSC -0.093; TCGA KIRP -0.097; TCGA LGG -0.19; TCGA PRAD -0.074; TCGA SARC -0.209; TCGA THCA -0.074; TCGA STAD -0.249; TCGA UCEC -0.128 |
hsa-miR-500a-3p | UBE2H | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUAD; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.101; TCGA BRCA -0.136; TCGA ESCA -0.14; TCGA HNSC -0.257; TCGA KIRP -0.142; TCGA LUAD -0.074; TCGA PAAD -0.214; TCGA THCA -0.065; TCGA STAD -0.097 |
hsa-miR-500a-3p | ADAMTSL3 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; OV; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.722; TCGA BRCA -0.17; TCGA CESC -0.347; TCGA COAD -0.792; TCGA HNSC -0.602; TCGA LIHC -0.366; TCGA OV -0.227; TCGA PRAD -0.505; TCGA THCA -0.215; TCGA STAD -0.792; TCGA UCEC -0.462 |
hsa-miR-500a-3p | ARIH1 | 10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.11; TCGA BRCA -0.087; TCGA HNSC -0.09; TCGA LGG -0.061; TCGA LIHC -0.082; TCGA LUAD -0.094; TCGA PAAD -0.122; TCGA PRAD -0.093; TCGA SARC -0.102; TCGA STAD -0.053 |
hsa-miR-500a-3p | BHMT2 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.515; TCGA COAD -0.916; TCGA ESCA -0.325; TCGA HNSC -0.25; TCGA LUSC -0.313; TCGA PRAD -0.507; TCGA SARC -0.672; TCGA STAD -0.851; TCGA UCEC -0.296 |
hsa-miR-500a-3p | KLF9 | 11 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.359; TCGA BRCA -0.229; TCGA COAD -0.489; TCGA HNSC -0.14; TCGA LIHC -0.424; TCGA LUAD -0.105; TCGA LUSC -0.225; TCGA PRAD -0.117; TCGA SARC -0.131; TCGA STAD -0.542; TCGA UCEC -0.26 |
hsa-miR-500a-3p | NFASC | 10 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.442; TCGA COAD -0.291; TCGA ESCA -0.536; TCGA HNSC -0.27; TCGA LIHC -0.198; TCGA LUSC -0.29; TCGA PRAD -0.328; TCGA SARC -0.98; TCGA STAD -0.795; TCGA UCEC -0.363 |
hsa-miR-500a-3p | SH3RF3 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.253; TCGA CESC -0.257; TCGA COAD -0.266; TCGA ESCA -0.167; TCGA HNSC -0.203; TCGA KIRC -0.27; TCGA LGG -0.117; TCGA LUSC -0.235; TCGA PRAD -0.201; TCGA STAD -0.287; TCGA UCEC -0.19 |
hsa-miR-500a-3p | PPP2R2C | 12 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.383; TCGA BRCA -0.36; TCGA ESCA -0.995; TCGA HNSC -0.235; TCGA KIRC -0.334; TCGA LUAD -0.44; TCGA LUSC -0.455; TCGA PAAD -0.619; TCGA PRAD -0.182; TCGA SARC -0.803; TCGA STAD -0.468; TCGA UCEC -0.312 |
hsa-miR-500a-3p | TSHZ3 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.572; TCGA BRCA -0.225; TCGA COAD -0.579; TCGA ESCA -0.572; TCGA HNSC -0.386; TCGA KIRC -0.122; TCGA KIRP -0.207; TCGA LGG -0.167; TCGA LIHC -0.232; TCGA LUAD -0.105; TCGA LUSC -0.537; TCGA PRAD -0.347; TCGA STAD -0.539; TCGA UCEC -0.495 |
hsa-miR-500a-3p | PLXDC2 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.521; TCGA CESC -0.185; TCGA COAD -0.643; TCGA ESCA -0.477; TCGA HNSC -0.246; TCGA KIRC -0.112; TCGA LUSC -0.275; TCGA OV -0.135; TCGA PRAD -0.201; TCGA THCA -0.257; TCGA STAD -0.354; TCGA UCEC -0.176 |
hsa-miR-500a-3p | ERC1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; OV; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.222; TCGA BRCA -0.05; TCGA COAD -0.083; TCGA ESCA -0.209; TCGA HNSC -0.279; TCGA LGG -0.137; TCGA LUAD -0.1; TCGA OV -0.089; TCGA PRAD -0.287; TCGA SARC -0.117; TCGA STAD -0.174 |
hsa-miR-500a-3p | SH3PXD2A | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; OV; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.367; TCGA BRCA -0.059; TCGA COAD -0.174; TCGA ESCA -0.179; TCGA HNSC -0.216; TCGA KIRC -0.371; TCGA LUSC -0.291; TCGA OV -0.128; TCGA PRAD -0.369; TCGA THCA -0.126; TCGA STAD -0.193; TCGA UCEC -0.17 |
hsa-miR-500a-3p | IGF1R | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.309; TCGA BRCA -0.595; TCGA CESC -0.142; TCGA COAD -0.109; TCGA ESCA -0.348; TCGA HNSC -0.289; TCGA LGG -0.262; TCGA LIHC -0.242; TCGA LUAD -0.175; TCGA LUSC -0.233; TCGA OV -0.266; TCGA PAAD -0.196; TCGA PRAD -0.119; TCGA SARC -0.241; TCGA THCA -0.229; TCGA STAD -0.179 |
hsa-miR-500a-3p | DST | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.352; TCGA BRCA -0.246; TCGA CESC -0.417; TCGA COAD -0.256; TCGA ESCA -0.312; TCGA HNSC -0.363; TCGA LGG -0.281; TCGA LIHC -0.086; TCGA LUSC -0.257; TCGA PRAD -0.386; TCGA SARC -0.187; TCGA THCA -0.339; TCGA STAD -0.445 |
hsa-miR-500a-3p | TBC1D2B | 10 cancers: BLCA; CESC; HNSC; KIRC; LIHC; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.137; TCGA CESC -0.146; TCGA HNSC -0.134; TCGA KIRC -0.353; TCGA LIHC -0.117; TCGA LUSC -0.132; TCGA PRAD -0.118; TCGA THCA -0.055; TCGA STAD -0.11; TCGA UCEC -0.218 |
hsa-miR-500a-3p | TOM1L2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.083; TCGA BRCA -0.248; TCGA COAD -0.12; TCGA ESCA -0.167; TCGA HNSC -0.124; TCGA LGG -0.081; TCGA OV -0.079; TCGA SARC -0.211; TCGA STAD -0.297; TCGA UCEC -0.225 |
hsa-miR-500a-3p | FAM26E | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.277; TCGA BRCA -0.173; TCGA COAD -0.532; TCGA ESCA -0.253; TCGA HNSC -0.326; TCGA LIHC -0.126; TCGA LUAD -0.126; TCGA LUSC -0.472; TCGA STAD -0.173; TCGA UCEC -0.322 |
hsa-miR-500a-3p | OTUD4 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.118; TCGA BRCA -0.057; TCGA ESCA -0.078; TCGA HNSC -0.245; TCGA KIRP -0.142; TCGA LGG -0.066; TCGA LIHC -0.195; TCGA LUAD -0.071; TCGA PAAD -0.122; TCGA PRAD -0.18; TCGA THCA -0.077 |
hsa-miR-500a-3p | C16orf52 | 10 cancers: BLCA; BRCA; CESC; KIRP; LGG; LIHC; OV; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.1; TCGA BRCA -0.175; TCGA CESC -0.088; TCGA KIRP -0.101; TCGA LGG -0.071; TCGA LIHC -0.146; TCGA OV -0.05; TCGA PAAD -0.114; TCGA STAD -0.068; TCGA UCEC -0.171 |
hsa-miR-500a-3p | FNDC3B | 10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.1; TCGA CESC -0.136; TCGA HNSC -0.278; TCGA KIRC -0.252; TCGA KIRP -0.219; TCGA LUAD -0.098; TCGA LUSC -0.269; TCGA PAAD -0.297; TCGA PRAD -0.198; TCGA THCA -0.066 |
hsa-miR-500a-3p | RUNX1T1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUSC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.573; TCGA BRCA -0.475; TCGA COAD -0.657; TCGA ESCA -0.37; TCGA HNSC -0.621; TCGA LGG -0.546; TCGA LUSC -0.446; TCGA PRAD -0.646; TCGA SARC -0.158; TCGA STAD -0.639; TCGA UCEC -0.44 |
hsa-miR-500a-3p | NBEA | 9 cancers: BLCA; BRCA; COAD; HNSC; LGG; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.55; TCGA BRCA -0.714; TCGA COAD -1.039; TCGA HNSC -0.326; TCGA LGG -0.341; TCGA PRAD -0.304; TCGA SARC -0.416; TCGA STAD -0.896; TCGA UCEC -0.452 |
hsa-miR-500a-3p | ANKRD13A | 9 cancers: BLCA; CESC; ESCA; KIRC; LGG; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.061; TCGA CESC -0.093; TCGA ESCA -0.075; TCGA KIRC -0.184; TCGA LGG -0.059; TCGA PRAD -0.121; TCGA SARC -0.066; TCGA STAD -0.133; TCGA UCEC -0.052 |
hsa-miR-500a-3p | GPM6A | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LIHC; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.493; TCGA BRCA -0.431; TCGA COAD -1.503; TCGA ESCA -1.416; TCGA HNSC -0.341; TCGA LGG -0.366; TCGA LIHC -0.838; TCGA PRAD -0.48; TCGA SARC -0.344; TCGA STAD -1.567; TCGA UCEC -0.729 |
hsa-miR-500a-3p | ATP2A2 | 9 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC | miRNATAP | TCGA BLCA -0.119; TCGA CESC -0.126; TCGA HNSC -0.28; TCGA KIRP -0.082; TCGA LGG -0.117; TCGA LUAD -0.096; TCGA PAAD -0.11; TCGA PRAD -0.212; TCGA SARC -0.182 |
hsa-miR-500a-3p | LIMCH1 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PRAD; STAD | MirTarget | TCGA BRCA -0.232; TCGA CESC -0.321; TCGA COAD -0.264; TCGA ESCA -0.223; TCGA HNSC -0.44; TCGA LIHC -0.378; TCGA LUSC -0.288; TCGA PRAD -0.198; TCGA STAD -0.301 |
hsa-miR-500a-3p | GOLGA2 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; UCEC | MirTarget | TCGA BRCA -0.114; TCGA CESC -0.094; TCGA COAD -0.08; TCGA ESCA -0.073; TCGA HNSC -0.184; TCGA KIRC -0.051; TCGA KIRP -0.053; TCGA PAAD -0.174; TCGA UCEC -0.064 |
hsa-miR-500a-3p | ARHGAP29 | 9 cancers: BRCA; CESC; COAD; HNSC; KIRP; LIHC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.197; TCGA CESC -0.218; TCGA COAD -0.302; TCGA HNSC -0.43; TCGA KIRP -0.266; TCGA LIHC -0.167; TCGA THCA -0.119; TCGA STAD -0.128; TCGA UCEC -0.318 |
hsa-miR-500a-3p | TANC2 | 15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.277; TCGA CESC -0.358; TCGA COAD -0.496; TCGA ESCA -0.283; TCGA HNSC -0.367; TCGA KIRP -0.179; TCGA LGG -0.392; TCGA LIHC -0.22; TCGA LUAD -0.088; TCGA LUSC -0.252; TCGA PAAD -0.246; TCGA PRAD -0.072; TCGA THCA -0.127; TCGA STAD -0.179; TCGA UCEC -0.197 |
hsa-miR-500a-3p | TRERF1 | 10 cancers: BRCA; CESC; COAD; HNSC; LGG; LUAD; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.255; TCGA CESC -0.237; TCGA COAD -0.294; TCGA HNSC -0.165; TCGA LGG -0.309; TCGA LUAD -0.097; TCGA OV -0.171; TCGA PRAD -0.295; TCGA STAD -0.105; TCGA UCEC -0.2 |
hsa-miR-500a-3p | NR1D2 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; OV; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.106; TCGA HNSC -0.135; TCGA LGG -0.109; TCGA LIHC -0.073; TCGA LUAD -0.067; TCGA OV -0.139; TCGA PRAD -0.125; TCGA STAD -0.074; TCGA UCEC -0.13 |
hsa-miR-500a-3p | CACNB1 | 9 cancers: KIRC; KIRP; LGG; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA KIRC -0.467; TCGA KIRP -0.31; TCGA LGG -0.135; TCGA OV -0.171; TCGA PAAD -0.286; TCGA PRAD -0.132; TCGA SARC -0.139; TCGA THCA -0.402; TCGA UCEC -0.145 |
Enriched cancer pathways of putative targets